Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial

Joseph A. Murray, Dina Wassaf, Karen Dunn, Samir Arora, Peter Winkle, Helen Stacey, Simon Cooper, Kaela E. Goldstein, Rajesh Manchanda, Stephan Kontos, Kristie M. Grebe

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences